Identification of <i><scp>ZDHHC14</scp></i> as a novel human tumour suppressor gene
Marc Yeste‐Velasco(Queen Mary University of London), Yong‐Jie Lu(Queen Mary University of London), Tracy Chaplin(Queen Mary University of London), Gareth M. Thomas(Temple University), Attila T. Lörincz(Queen Mary University of London), Maojia Xu(Queen Mary University of London), Richard Grose(University of Liverpool), Xueying Mao(Ministry of Education), Athina‐Myrto Chioni(Kingston University), Bryan D. Young(The University of Texas Southwestern Medical Center), Jacek Marzec(Queen Mary University of London), Claude Chelala(Queen Mary University of London), Daniel M. Berney(Queen Mary University of London), R.T.D. Oliver(University of Cambridge), Santi Karnam(Temple University Hospital), Julie Foster(Queen Mary University of London), Liyan Xue(Queen Mary University of London), Dongmei Lin(Queen Mary University of London), David Gould(University of Iowa), Sharon Y. James(Queen Mary University of London), Sakunthala C. Kudahetti(Queen Mary University of London), Janet Shipley(Institute of Cancer Research), Stephen J. Mather(St Bartholomew's Hospital), Nataša Vasiljević(Queen Mary University of London)
Cited by 94
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
The causal link between human papillomavirus and invasive cervical cancer: A population‐based case‐control study in colombia and spain
|International Journal of Cancer|1992|576
Histone Deacetylase 7 Maintains Vascular Integrity by Repressing Matrix Metalloproteinase 10
|Cell|2006|460
Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial
|The Lancet|2005|447
Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial.
|Journal of Clinical Oncology|1997|334